Business Description
Precigen Inc. is a biopharmaceutical company based in Germantown, Maryland, focused on developing advanced gene and cell therapies for cancer, autoimmune conditions, and infectious diseases. Founded in 1998 and formerly known as Intrexon Corporation, the company works with two core treatment platforms ? AdenoVerse, which uses proprietary gene delivery technology to stimulate immune responses, and UltraCAR-T, which engineers a patient's own immune cells to fight cancer. Several treatments built on these platforms are currently being tested in clinical trials, targeting cancers such as ovarian cancer, leukemia, and HPV-related tumors, among others.
